CRISPR/Cas9 Shown to Limit Impact of Schistosomiasis (IMAGE)
Caption
George Washington University researchers 'knocked out' the omega-1 ribonuclease protein using CRISPR/Cas9 and found that it greatly reduced the impact of schistosomiasis.
Credit
GW School of Medicine and Health Sciences
Usage Restrictions
None
License
Licensed content